Juan Li

机构：Sichuan University, State Key Laboratory of Oral Diseases · ORCID：0000-0002-1246-9610

发表论文 219 篇 · 总被引 4641 次 · h-index 33

代表论文

• Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial (2025 · The Lancet · 被引 33)
• Fusobacterium mortiferum and its metabolite 5-aminovaleric acid promote the development of colorectal cancer in obese individuals through Wnt/β-catenin pathway by DKK2 (2025 · Gut Microbes · 被引 18)
• CsMYB219 and CsMYB196 influence epigallocatechin gallate biosynthesis in tea plant ( Camellia sinensis ) by regulating CsSCPL1A gene expression (2025 · The Plant Journal · 被引 13)
• Hypothalamic GABAergic neurons: their roles in health and metabolic diseases (2025 · Frontiers in Endocrinology · 被引 10)
• CsMYB213‐CsbHLH35 module regulates theanine biosynthesis in tea plants ( Camellia sinensis L.) (2025 · Plant Biotechnology Journal · 被引 9)
• Current landscape of BRD4 inhibitors: Selective targeting and protein degradation for enhanced efficacy (2025 · Results in Chemistry · 被引 5)